Interleukin 8 promoter polymorphism predicts the initial response to bevacizumab treatment for exudative age-related macular degeneration. (Record no. 22668093)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02213 a2200637 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516144236.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201402s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1539-2864 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/IAE.0b013e318285cf92 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hautamäki, Asta |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20140219 |
245 00 - TITLE STATEMENT | |
Title | Interleukin 8 promoter polymorphism predicts the initial response to bevacizumab treatment for exudative age-related macular degeneration. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Retina (Philadelphia, Pa.) |
Date of publication, distribution, etc. | Oct 2013 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1815-27 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Alleles |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angiogenesis Inhibitors |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Complement C3 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Complement Factor H |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Exudates and Transudates |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Genotype |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-8 |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intravitreal Injections |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pharmacogenetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymorphism, Single Nucleotide |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Promoter Regions, Genetic |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proteins |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tomography, Optical Coherence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vascular Endothelial Growth Factor A |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Visual Acuity |
General subdivision | physiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Wet Macular Degeneration |
General subdivision | diagnosis |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kivioja, Jarno |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vavuli, Satu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kakko, Sakari |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Savolainen, Eeva-Riitta |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Savolainen, Markku J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liinamaa, M Johanna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Seitsonen, Sanna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Onkamo, Päivi |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Järvelä, Irma |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Immonen, Ilkka |
773 0# - HOST ITEM ENTRY | |
Title | Retina (Philadelphia, Pa.) |
Related parts | vol. 33 |
-- | no. 9 |
-- | p. 1815-27 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/IAE.0b013e318285cf92">https://doi.org/10.1097/IAE.0b013e318285cf92</a> |
Public note | Available from publisher's website |
No items available.